T1	Date 12 16	2020
T2	PROC 57 121	evaluar la eficacia, seguridad, farmacocinética y farmacodinamia
T3	CHEM 125 134	ponesimod
T4	CHEM 144 154	fingolimod
#1	AnnotatorNotes T4	C1699926; fingolimod; Immunologic Factor · Organic Chemical · Pharmacologic Substance
T5	Duration 163 174	108 semanas
T6	PROC 178 189	tratamiento
#2	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	LIVB 193 214	pacientes pediátricos
T8	Age 203 214	pediátricos
T9	Age 216 232	de 10 a <18 años
T10	DISO 238 278	esclerosis múltiple remitente recurrente
#3	AnnotatorNotes T10	C0751967; Multiple Sclerosis, Relapsing-Remitting; Disease or Syndrome
T11	PROC 299 439	Estudio multicéntrico, aleatorizado, doble ciego, de grupos paralelos, con doble simulación, controlado con tratamiento activo y comparativo
T12	PROC 445 509	evaluar la eficacia, seguridad, farmacocinética y farmacodinamia
T13	CHEM 513 522	ponesimod
T14	CHEM 532 542	fingolimod
#4	AnnotatorNotes T14	C1699926; fingolimod; Immunologic Factor · Organic Chemical · Pharmacologic Substance
T15	Duration 551 562	108 semanas
T16	PROC 566 577	tratamiento
#5	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	LIVB 581 602	pacientes pediátricos
T18	Age 591 602	pediátricos
T19	Age 604 620	de 10 a <18 años
T20	DISO 626 666	esclerosis múltiple remitente recurrente
#6	AnnotatorNotes T20	C0751967; Multiple Sclerosis, Relapsing-Remitting; Disease or Syndrome
T21	DISO 688 719	Enfermedad inflamatoria crónica
T22	Duration 712 719	crónica
T23	ANAT 733 736	SNC
#7	AnnotatorNotes T23	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T24	DISO 761 801	Esclerosis múltiple remitente recurrente
#8	AnnotatorNotes T24	C0751967; Multiple Sclerosis, Relapsing-Remitting; Disease or Syndrome
T25	PROC 833 844	diagnóstico
#9	AnnotatorNotes T25	C0011900; Diagnosis; Diagnostic Procedure
T26	DISO 848 888	esclerosis múltiple remitente-recurrente
#10	AnnotatorNotes T26	C0751967; Multiple Sclerosis, Relapsing-Remitting; Disease or Syndrome
T27	DISO 890 894	EMRR
#11	AnnotatorNotes T27	C0751967; Multiple Sclerosis, Relapsing-Remitting; Disease or Syndrome
T28	Date 937 941	2017
T29	PROC 989 997	revisión
#12	AnnotatorNotes T29	C0558347; Surgical revision; Therapeutic or Preventive Procedure | C1522577; follow-up; Health Care Activity
T30	PROC 1010 1021	diagnóstico
#13	AnnotatorNotes T30	C0011900; Diagnosis; Diagnostic Procedure
T31	DISO 1025 1044	esclerosis múltiple
#14	AnnotatorNotes T31	C0026769; Multiple Sclerosis; Disease or Syndrome
T32	DISO 1045 1049	(EM)
T33	LIVB 1076 1089	participantes
T34	PROC 1102 1108	Visita
T35	Date 1112 1117	Día 1
T36	PROC 1119 1133	aleatorización
#15	AnnotatorNotes T36	C0034656; Randomization; Research Activity
T37	PROC 1155 1197	Escala de Estado de Discapacidad Expandida
T38	PROC 1199 1203	EDSS
T39	DISO 1245 1252	recaída
#16	AnnotatorNotes T39	C2825055; Recurrence (disease attribute); Pathologic Function
T40	DISO 1259 1261	EM
#17	AnnotatorNotes T40	C0014742; Erythema Multiforme; Disease or Syndrome | C0015674; Chronic Fatigue Syndrome; Disease or Syndrome | C0026269; Mitral Valve Stenosis; Disease or Syndrome | C0026769; Multiple Sclerosis; Disease or Syndrome | C0264766; Rheumatic mitral stenosis; Disease or Syndrome
T41	Date 1270 1285	el año anterior
T42	DISO 1290 1298	recaídas
#18	AnnotatorNotes T42	C2825055; Recurrence (disease attribute); Pathologic Function
T43	DISO 1305 1307	EM
#19	AnnotatorNotes T43	C0014742; Erythema Multiforme; Disease or Syndrome | C0015674; Chronic Fatigue Syndrome; Disease or Syndrome | C0026269; Mitral Valve Stenosis; Disease or Syndrome | C0026769; Multiple Sclerosis; Disease or Syndrome | C0264766; Rheumatic mitral stenosis; Disease or Syndrome
T44	Duration 1311 1332	los 2 años anteriores
T45	PROC 1394 1426	imágenes de resonancia magnética
T46	PROC 1428 1431	IRM
#20	AnnotatorNotes T46	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T47	Duration 1433 1440	6 meses
T48	PROC 1453 1459	Visita
T49	Date 1463 1468	Día 1
T50	PROC 1470 1484	Aleatorización
#21	AnnotatorNotes T50	C0034656; Randomization; Research Activity
T51	PROC 1501 1504	IRM
#22	AnnotatorNotes T51	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T52	PROC 1511 1517	Visita
T53	LIVB 1581 1593	investigador
#23	AnnotatorNotes T53	C0035173; Research Personnel; Professional or Occupational Group
T54	PROC 1617 1635	exploración física
#24	AnnotatorNotes T54	C0031809; Physical Examination; Health Care Activity
T55	PROC 1662 1676	signos vitales
T56	PROC 1682 1704	pruebas de laboratorio
#25	AnnotatorNotes T56	C0022885; Laboratory Procedures; Laboratory Procedure
T57	PROC 1710 1728	electrocardiograma
#26	AnnotatorNotes T57	C0013798; Electrocardiogram; Diagnostic Procedure | C1623258; Electrocardiography; Diagnostic Procedure
T58	PROC 1730 1733	ECG
#27	AnnotatorNotes T58	C1623258; Electrocardiography; Diagnostic Procedure
T59	PROC 1741 1747	visita
T60	DISO 1773 1784	anormalidad
#28	AnnotatorNotes T60	C1704258; Abnormality; Finding
T61	LIVB 1905 1917	participante
T62	LIVB 1940 1962	investigador principal
#29	AnnotatorNotes T62	C1521895; Principal Investigator; Professional or Occupational Group
T63	LIVB 1964 1966	IP
T64	LIVB 1971 1984	Participantes
T65	PROC 1989 1993	peso
T66	PROC 1996 2015	superficie corporal
T67	LIVB 2075 2088	participantes
T68	DISO 2093 2102	sobrepeso
#30	AnnotatorNotes T68	C0497406; Overweight; Finding
T69	LIVB 2134 2147	participantes
T70	PROC 2152 2156	peso
T71	PROC 2215 2234	autorización médica
T72	PROC 2277 2288	diagnóstico
#31	AnnotatorNotes T72	C0011900; Diagnosis; Diagnostic Procedure
T73	DISO 2292 2294	EM
#32	AnnotatorNotes T73	C0014742; Erythema Multiforme; Disease or Syndrome | C0015674; Chronic Fatigue Syndrome; Disease or Syndrome | C0026269; Mitral Valve Stenosis; Disease or Syndrome | C0026769; Multiple Sclerosis; Disease or Syndrome | C0264766; Rheumatic mitral stenosis; Disease or Syndrome
T74	DISO 2343 2365	EM primaria progresiva
T75	DISO 2368 2393	EM progresiva recidivante
T76	DISO 2398 2460	Alteraciones generalizadas y simétricas de la sustancia blanca
T77	PROC 2467 2469	RM
#33	AnnotatorNotes T77	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T78	Spec_cue 2482 2490	sugieren
T79	DISO 2497 2524	trastornos desmielinizantes
T80	Speculated 2497 2524	trastornos desmielinizantes
T81	DISO 2539 2561	trastornos metabólicos
#34	AnnotatorNotes T81	C0025517; Metabolic Diseases; Disease or Syndrome
T82	Speculated 2539 2561	trastornos metabólicos
T83	DISO 2563 2588	trastornos mitocondriales
#35	AnnotatorNotes T83	C0026244; Mitochondrial Swelling; Cell or Molecular Dysfunction | C0751651; Mitochondrial Diseases; Disease or Syndrome
T84	Speculated 2563 2588	trastornos mitocondriales
T85	CHEM 2617 2629	acuaporina 4
T86	CHEM 2631 2635	AQP4
T87	PROC 2639 2703	anticuerpos contra la glicoproteína oligodendrocítica de mielina
T88	PROC 2705 2708	MOG
T89	PROC 2716 2722	visita
T90	LIVB 2783 2788	mujer
#36	AnnotatorNotes T90	C0043210; Woman; Population Group | C0242665; wife; Family Group
T91	PHYS 2803 2813	concepción
#37	AnnotatorNotes T91	C0009637; Conception; Organism Function
T92	PHYS 2843 2852	gestación
#38	AnnotatorNotes T92	C0032961; Pregnancy; Organism Function
T93	PROC 2873 2928	prueba de laboratorio de gonadotropina coriónica humana
T94	PHYS 2956 2965	lactancia
#39	AnnotatorNotes T94	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T95	LIVB 3092 3104	investigador
#40	AnnotatorNotes T95	C0035173; Research Personnel; Professional or Occupational Group
T96	Neg_cue 3123 3125	no
T97	Negated 3130 3141	conveniente
T98	LIVB 3150 3162	participante
T99	Speculated 3220 3227	impedir
T100	Speculated 3229 3236	limitar
T101	Speculated 3239 3248	confundir
T102	PROC 3253 3265	evaluaciones
#41	AnnotatorNotes T102	C1261322; Evaluation procedure; Health Care Activity
T103	PROC 3286 3295	protocolo
#42	AnnotatorNotes T103	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T104	PROC 44 51	Estudio
T105	PROC 949 970	criterios de McDonald
T106	CHEM 1371 1380	gadolinio
T107	CHEM 1382 1384	Gd
T108	PROC 1640 1656	historia clínica
T109	DISO 1825 1838	EM pediátrica
T110	Age 1828 1838	pediátrica
T111	PHYS 2740 2750	Embarazada
T112	PROC 2593 2599	Prueba
T113	PHYS 2987 2997	embarazada
T114	PROC 3033 3040	estudio
T115	Quantifier_or_Qualifier 1050 1060	pediátrica
T116	Quantifier_or_Qualifier 1109 1110	3
T117	Result_or_Value 1205 1218	entre 0 y 5,5
T118	Quantifier_or_Qualifier 1234 1244	Al menos 1
T119	Quantifier_or_Qualifier 1288 1289	2
T120	Quantifier_or_Qualifier 1460 1461	3
T121	Quantifier_or_Qualifier 1518 1519	2
T122	CONC 1521 1527	Inicio
T123	Observation 1544 1549	sanos
T124	CONC 1640 1656	historia clínica
T125	Quantifier_or_Qualifier 1748 1749	1
T126	Observation 1773 1784	anormalidad
T127	Quantifier_or_Qualifier 1828 1838	pediátrica
T128	Result_or_Value 2016 2046	entre el 5º y el 95º percentil
T129	Result_or_Value 2103 2127	superior al percentil 95
T130	Result_or_Value 2157 2180	inferior al percentil 5
T131	Observation 2188 2198	participar
T132	Observation 2299 2315	curso progresivo
T133	CONC 2325 2331	inicio
T134	Quantifier_or_Qualifier 2346 2354	primaria
T135	Quantifier_or_Qualifier 2355 2365	progresiva
T136	Observation 2382 2393	recidivante
T137	Result_or_Value 2600 2608	positiva
T138	Quantifier_or_Qualifier 2723 2724	1
T139	Result_or_Value 2929 2937	positiva
T140	Observation 2973 2997	planea quedar embarazada
T141	Quantifier_or_Qualifier 3130 3141	conveniente
T142	Observation 3177 3204	comprometiendo su bienestar
T143	CONC 3229 3236	limitar
T144	CONC 3239 3248	confundir
T145	Patient 193 214	pacientes pediátricos
T146	Patient 581 602	pacientes pediátricos
T147	Patient 1076 1089	participantes
T148	History_of 1259 1261	EM
T149	History_of 1305 1307	EM
T150	Other 1581 1593	investigador
T151	Patient 1905 1917	participante
T152	Other 1940 1962	investigador principal
T153	Other 1964 1966	IP
T154	Patient 1971 1984	Participantes
T155	Patient 2075 2088	participantes
T156	Patient 2134 2147	participantes
T157	Patient 2783 2788	mujer
T158	Future 2987 2997	embarazada
T159	Other 3092 3104	investigador
T160	Patient 3150 3162	participante
